Study guide

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes

NCRA Oncology Data Specialist ODS-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters

1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish

2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws

2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority

3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance

3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance

4 Chapter 4: Registry Organization, Staffing & Information Systems

4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning

5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement

5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)

6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality

6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)

7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics

7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data

8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer

8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors

9 Chapter 9: Casefinding & Reportability

9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"

10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators

10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More

11 Chapter 11: Class of Case, Key Dates & Case Identifiers

11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them

12 Chapter 12: Follow-Up, Vital Status & Recurrence

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary

13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade

13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables

14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules

14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules

15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018

15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples

16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS

16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes

Key Takeaways Explain This Topic AI

STORE requires follow-up at least annually for all living Class of Case 10–22 patients; CoC does not require Class 00 cases or foreign residents to be followed.

Follow-up also completes missing first-course treatment, for example when surgery is delayed six months or more after Date of First Contact, or when planned therapy is coded 88 or 8 as a tickler.

Active follow-up contacts a physician, the patient, or another facility directly; passive follow-up links registry records to outside files such as death indexes, hospital admissions, or motor vehicle and Medicare records.

Follow-Up Source [1790] records where the latest information came from: 0 reported hospitalization, 1 readmission, 2 physician, 3 patient, 4 DMV, 5 Medicare or Medicaid, 7 death certificate, 8 other, 9 unknown.

Next Follow-Up Source [1800] records the planned method: 0 chart requisition, 1 physician letter, 2 contact letter, 3 phone call, 4 other hospital contact, 5 other, 8 foreign resident (not followed), 9 not followed.

Last updated: September 2026

Why registries follow patients

The CoC standard on follow-up says it plainly: "Long-term follow-up is essential to evaluate outcomes of cancer care," and accurate follow-up data let a program compare its outcomes with regional, state or national statistics. Follow-up supports:

Survival analysis , which needs an accurate date of last contact or death and vital status for every patient (Section 7.5).

Recurrence and disease-free interval , which measure how well first-course treatment worked (Section 12.4).

Complete first-course treatment , because an abstract is often finished before all planned therapy is given.

Quality measures and research , including NCDB benchmark reports and special studies.

Continuity of care , because registry contact can remind patients and physicians about surveillance visits.

What STORE says must be followed

STORE's "Outcomes" chapter lists the follow-up duties for CoC programs:

Obtain follow-up at least annually for all living Class of Case 10–22 patients in the registry database.

Complete first-course treatment information:

when Rx Summ–Surg 2023 [1291] is delayed six months or more after Date of First Contact [580];

for Readmission to the Same Hospital Within 30 Days of Surgical Discharge [3190] after the most definitive surgery;

for radiation, chemotherapy, hormone therapy, immunotherapy, transplant or endocrine procedures, or other treatment that was planned but not started or finished at the last follow-up. "Reason for no" codes 88 or 8 act as ticklers to flag incomplete treatment.

Once all planned first-course treatment is recorded, treatment items no longer need follow-up.

Follow recurrence until a recurrence is reported or the patient dies (Section 12.4).

Keep Date of Last Contact or Death [1750] , Follow-Up Source [1790] and Next Follow-Up Source [1800] current while the patient is alive.

Once the death and all care before death are recorded, stop follow-up.

Exemptions: CoC does not require Class of Case 00 cases to be followed (since January 1, 2006), and registries are not required to follow foreign residents . CoC Standard 6.5 also exempts cases reportable by agreement and patients over 100 years old with no contact for more than 12 months when computing follow-up rates (Section 12.2).

Active versus passive follow-up

Active follow-up Passive follow-up

How The registry contacts a source directly and asks for the patient's status The registry matches its records against outside files without contacting anyone

Examples Letters, portal messages or calls to the following physician; letters or calls to the patient or a contact person; queries to another hospital State death files and the National Death Index; hospital admission and discharge feeds; state central registry updates; motor vehicle or Medicare/Medicaid records; obituaries and online death indexes

Strengths Gives cancer status and recurrence detail from a physician Efficient for large populations; finds deaths the physician may not know about

Weaknesses Staff time, postage, response rates, patient burden Usually gives only vital status and date; missing a match does not prove a patient is alive

Typical user Hospital registries meeting CoC follow-up rates Central registries and population-based survival programs

Most hospital registries combine both. They routinely check the facility's own admissions and outpatient visits and match against death files, then send physician letters for patients still not current. Central registries depend mainly on linkage, including state and national death files, because population-based survival needs vital status for everyone.

Sources CoC names

Standard 6.5 lists methods "including, but not limited to":

The following or managing physician.

The program's inpatient or outpatient services.

Pathology reports or death certificates.

Internet sources, such as death indexes, patient locator software and obituary listings.

Communication with other facilities.

Privacy considerations

Follow-up is a registry operation that uses protected health information. Disclosures to a state registry are permitted as public health reporting under HIPAA (Section 2.1). Many facilities require the managing physician's permission before the registry contacts a patient directly, and letters should not reveal the diagnosis on the envelope or to anyone other than the patient. Check facility and state policy.

Follow-Up Source [1790]

Code Label Meaning

0 Reported hospitalization Hospitalization at another institution, or first admission to the reporting facility

  • 1 Readmission Hospitalization or outpatient visit at the reporting facility
  • 2 Physician Information from a physician
  • 3 Patient Direct contact with the patient
  • 4 Department of Motor Vehicles DMV confirmed a current license
  • 5 Medicare/Medicaid file Medicare or Medicaid office confirmed the patient is alive
  • 7 Death certificate Information from the death certificate only
  • 8 Other Friends, relatives, employers, other registries, or other sources
  • 9 Unknown Source unknown or not stated
  • Next Follow-Up Source [1800]
  • Code Planned method
  • 0 Chart requisition
  • 1 Physician letter
  • 2 Contact letter
  • 3 Phone call
  • 4 Other hospital contact
  • 5 Other, NOS
  • 8 Foreign residents (not followed)
  • 9 Not followed; other cases for which follow-up is not required
  • Key rule: who can update cancer status

Contact from the patient or family updates Date of Last Contact or Death and Vital Status , but not Cancer Status . STORE allows Cancer Status to change only on information from the patient's physician or another official source , such as a death certificate (Section 12.3).

Loading diagram... Annual follow-up cycle